Sunworks (SUNW) Stock Price, News & Analysis

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sunworks in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SUNW shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SUNW, but not buy additional shares or sell existing shares.
View SUNW analyst ratings or view top-rated stocks.

1 brokerages have issued 1 year price objectives for Sunworks' stock. Their SUNW share price targets range from $1.20 to $1.20. On average, they anticipate the company's stock price to reach $1.20 in the next twelve months.
View analysts price targets for SUNW or view top-rated stocks among Wall Street analysts.

Sunworks, Inc. (NASDAQ:SUNW) issued its earnings results on Thursday, November, 11th. The semiconductor company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.18) by $0.06. The semiconductor company had revenue of $31.22 million for the quarter. Sunworks had a negative net margin of 40.36% and a negative trailing twelve-month return on equity of 127.97%. During the same quarter in the prior year, the firm earned ($0.17) EPS.

Sunworks's stock reverse split on Friday, August 30th 2019. The 1-7 reverse split was announced on Thursday, August 29th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 29th 2019. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sunworks investors own include Advanced Micro Devices (AMD), Plug Power (PLUG), Biocept (BIOC), iBio (IBIO), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Nokia Oyj (NOK), Onconova Therapeutics (ONTX) and VBI Vaccines (VBIV).